Introduction
Aortic stenosis (AS) is the most common primary valve disease requiring intervention in Europe and North America. The prevalence of AS increases with age, and degenerative AS is the most common type followed by AS secondary to a congenital bicuspid aortic valve.1,2 Prognosis of severe symptomatic AS is poor, with a reported 30–50% mortality at one year for patients who do not undergo any intervention.3,4
The optimal management of severe symptomatic AS in patients, often with multiple comorbidities, requires a multi-disciplinary team approach. The conservative approach with medical treatment of symptoms is associated with extre
